ArticleCell death & disease2016

SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.

T T Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.